Ethica Picks Alion for Human Research Protection Accreditation

Ethica Picks Alion for Human Research Protection Accreditation
Ethica Clinical Research has chosen Alion for accreditation of its Human Research Protection Program (HRPP).

The Canadian contract research organization (CRO) has been accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) – a voluntary peer-driven group that assess patient safety and ethical concerns - since 2006 and has now chosen Alion Science and Technology Corporation’s HRPP accreditation services for further endorsement.

Ethica’s President Dr. Janice Parente said in a press release: “We saw in Alion an accrediting body that better supports our mission, offers flexible, responsive service, and aligns with our business activities.”

She continued, adding: “Given the dynamic nature of the research and business environments in which we operate, we share the belief that accreditation must be an equally dynamic and evolutionary process.”

The company had considered a number of HRPP service providers, factoring in experience, governance, reputation, rigor, transparency and level of resources dedicated to their accreditation programs before selecting Alion.

The company was the first Canadian firm to gain accreditation, and the first CRO to gain it worldwide from the AAHRPP.

Since then, uptake has been slow though US CRO Celerion was awarded full accreditation last year with CEO Marjorie Speers hoping the certification would have “a ripple effect across the research enterprise and that other CROs follow the lead.”

According to the AAHRP​, the goals of accreditation are to improve the systems that protect the rights and welfare of individuals who participate in research and communicate to the public the strength of commitment to the protection of human research participants.

Accredited organisations must renew their approvals three years after the initial accreditation and five years thereafter. It is necessary to perform a self-assessment and gap analysis for both the initial application and each renewal.

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars